- Fosun Pharma began internal reorganization of its Sisram Medical stake on April 8, 2026, shifting holdings from Ample Up and Chindex to indirect unit Fosun Pharma Industrial.
- Ample Up will transfer 207,186,160 Sisram shares, equal to 44.2% of issued shares.
- Chindex will transfer 127,318,640 shares, equal to 27.2%.
- Completion would leave Fosun Pharma Industrial holding 334,504,800 shares, equal to 71.4% of voting rights.
- Regulator granted Fosun Pharma waiver from mandatory general offer requirement tied to voting rights increase.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260408-12098416), on April 08, 2026, and is solely responsible for the information contained therein.
Comments